{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:31:56Z","timestamp":1786422716934,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Although active surveillance (AS) is increasingly recommended for low risk papillary thyroid microcarcinoma (PTMC), a subset of patients with clinically node-negative (cN0) disease actually harbor occult lymph node metastasis (LNM), which may lead to delayed surgical intervention and poorer outcomes. This study aimed to identify independent risk factors for LNM in cN0 PTMC patients to refine preoperative risk stratification and guide individualized treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 2097 cN0 PTMC patients who underwent thyroidectomy with central lymph node dissection at Tianjin Cancer Hospital Airport Hospital between September 2019 and March 2025. Preoperative clinical, ultrasonographic, and laboratory data were collected. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of LNM. Receiver operating characteristic (ROC) curve analysis was used to evaluate predictive efficacy and determine optimal cut-off values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Postoperative LNM was confirmed in 865 patients (41.2%). Multivariate analysis identified male sex (OR\u00a0=\u00a02.108, 95% CI: 1.632-2.723), younger age (OR\u00a0=\u00a00.964, 95% CI: 0.954-0.974), larger tumor diameter (OR\u00a0=\u00a04.001, 95% CI: 2.329-6.871), multifocality (OR\u00a0=\u00a01.300, 95% CI: 1.037-1.629), BRAF V600E mutation (OR\u00a0=\u00a08.938, 95% CI: 6.900-11.579), and higher neutrophil-to-lymphocyte ratio (NLR) (OR\u00a0=\u00a011.158, 95% CI: 8.221-15.138) as independent risk factors for LNM (all\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.05). ROC analysis revealed optimal cut-off values of \u226443.5 years for age, \u22650.65 cm for tumor diameter, and \u22651.925 for NLR. BRAF V600E mutation and NLR demonstrated the highest predictive efficacy (AUC\u00a0=\u00a00.720 and 0.759, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In cN0 PTMC patients, male sex, age \u226443.5 years, tumor diameter \u22650.65 cm, multifocality, BRAF V600E mutation, and NLR \u22651.925 are independently associated with increased risk of cervical LNM. Preoperative assessment of these factors enables refined risk stratification for patients being considered for AS, facilitating more precise and individualized surveillance strategies. These findings underscore the importance of integrating clinical, pathological, and molecular parameters in PTMC risk stratification. Future prospective studies are warranted to validate whether early surgical intervention confers superior survival benefits over continued AS in high risk subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1839787","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:43Z","timestamp":1786422043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors associated with lymph node metastasis in cN0 papillary thyroid microcarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Shijie","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Head and Neck Oncology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangwu","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Oncology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Oncology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Oncology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Oncology, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer","place":["Tianjin, China"]},{"name":"Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin\u2019s Clinical Research Center for Cancer","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00448-z","article-title":"Current practice in patients with differentiated thyroid cancer","volume":"17","author":"Schlumberger","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10144","article-title":"Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection","volume":"103","author":"Lee","year":"2016","journal-title":"Br J Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"307-341","DOI":"10.3803\/EnM.2025.2461","article-title":"2025 korean thyroid association clinical management guideline on active surveillance for low-risk papillary thyroid carcinoma","volume":"40","author":"Ek","year":"2025","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2023.1794","article-title":"Active surveillance for low-risk papillary thyroid carcinoma as an acceptable management option with additional benefits: a comprehensive systematic review","volume":"39","author":"Yoon","year":"2024","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 american thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230006","article-title":"US predictors of papillary thyroid microcarcinoma progression at active surveillance","volume":"309","author":"Lee","year":"2023","journal-title":"Radiology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05215-4","article-title":"Does the ATA risk stratification apply to patients with papillary thyroid microcarcinoma","volume":"44","author":"Stefanova","year":"2020","journal-title":"World J Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejrad.2019.01.006","article-title":"Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases","volume":"112","author":"Zhao","year":"2019","journal-title":"Eur J Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1620085","article-title":"Multi-omics analysis and metastasis risk factor prediction in N1b stage PTMC: insights into immune infiltration and therapeutic implications","volume":"16","author":"Dai","year":"2025","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0285","article-title":"Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis","volume":"90","author":"Leboulleux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.3387","article-title":"Diagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid cancer cervical lymph node metastasis: a systematic review and meta-analysis","volume":"148","author":"Alabousi","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1108125","article-title":"Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0250","article-title":"Young age and Male sex are predictors of large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinomas","volume":"27","author":"Oh","year":"2017","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.574774","article-title":"Predictive factor of large-volume central lymph node metastasis in clinical N0 papillary thyroid carcinoma patients underwent total thyroidectomy","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1235354","article-title":"Risk prediction for <1 cm lateral lymph node metastasis in papillary thyroid microcarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318292b780","article-title":"Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma","volume":"37","author":"Bansal","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1537386","article-title":"Predicting central lymph node metastasis in papillary thyroid microcarcinoma: a breakthrough with interpretable machine learning","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.06.015","article-title":"Significance of multifocality in papillary thyroid carcinoma","volume":"46","author":"Feng","year":"2020","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415626","article-title":"Association of BRAFV600E mutation with the aggressive behavior of papillary thyroid microcarcinoma: a meta-analysis of 33 studies","volume":"23","author":"Attia","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2016(06)04","article-title":"Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer","volume":"71","author":"Gong","year":"2016","journal-title":"Clin (Sao Paulo Braz)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.292","article-title":"A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer","volume":"107","author":"Proctor","year":"2012","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0089-6","article-title":"Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas","volume":"46","author":"Kim","year":"2014","journal-title":"Endocrine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1330896","article-title":"The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with hashimoto\u2019s thyroiditis","volume":"15","author":"Lin","year":"2024","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-024-08990-6","article-title":"Treatment regimens for laryngeal and hypopharyngeal squamous cell carcinoma: a \u201creal life\u201d multicenter study of 2307 patients","volume":"282","author":"Knopf","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-05838-7","article-title":"Surgical nodal management in hypopharyngeal and laryngeal cancer","volume":"277","author":"Ketterer","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1839787\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:44Z","timestamp":1786422044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1839787\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":28,"alternative-id":["10.3389\/fonc.2026.1839787"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1839787","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1839787"}}